Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 561-567

  Brea, David ^a   Sobrino, Tomás ^a   Blanco, Miguel ^a   Fraga, Máximo ^b   Agulla, Jesús ^a   Rodríguez Yáñez, Manuel ^a   Rodríguez González, Raquel ^a   Pérez de la Ossa, Natalia ^c   Leira, Rogelio ^a   Forteza, Jerónimo ^b   Dávalos, Antonio ^c   Castillo, José ^a  

^a Acute Stroke Unit   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Atherothrombotic stroke; Cardioembolic stroke; Ischemic stroke classification; Proteomics

Indexed keywords

HAPTOGLOBIN; SERUM AMYLOID A;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN ATHEROSCLEROSIS; BRAIN EMBOLISM; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ELECTROPHORESIS;

AGED; BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPTOGLOBINS; HUMANS; ISCHEMIA; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID A PROTEIN; STROKE; THROMBOSIS;

EID: 67651102780     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.028     Document Type: Article

References (22)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., and Murray C.J. Global and regional burden of disease and risk factors 2001, systematic analysis of population health data. Lancet 367 (2006) 1747-1757
2. Schulz U.G.R., and Rothwell P.M. Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 34 (2003) 2050-2059
3. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 24 (1993) 35-41
4. Atiya M., Kurth T., Berger K., Buring J.E., and Kase C.S. Interobserver agreement in the classification of stroke in the Women's Health Study. Stroke 34 (2003) 565-567
5. Goldstein L.B., Jones M.R., Matchar D.B., et al. Improving the reliability of stroke subgroup classification using the trial of ORG 10172 in acute stroke treatment (TOAST) criteria. Stroke 32 (2001) 1091-1096
6. Gordon D.L., Bendixen B.H., Adams Jr. H.P., et al. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. Neurology 43 (1993) 1021-1027
7. Ay H., Furie K.L., Singhal A., Smith W.S., Sorensen A.G., and Koroshetz W.J. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 58 (2005) 688-697
8. Comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Guía para el diagnóstico y tratamiento del ictus. Prous Science. Barcelona; 2004.
9. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 24 (1993) 35-41
10. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
11. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 68 (1996) 850-858
12. Wan C., La Y., Zhu H., et al. Abnormal changes of plasma acute phase proteins in schizophrenia and the relation between schizophrenia and haptoglobin (Hp) gene. Amino acids 32 (2007) 101-108
13. Garcia-Gonzalez M., Abdulkader I., Boquete A.V., Neo X.M., Forteza J., and Cameselle-Teijeiro J. Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland. Virchows Arch 447 (2005) 12-17
14. Muranjan M., Nussenzweig V., and Tomlinson S. Characterization of the human serum trypanosome toxin, haptoglobin-related protein. J Biol Chem 273 (1998) 3884-3887
15. D'Armiento J., Dalal S.S., and Chada K. Tissue, temporal and inducible expression pattern of haptoglobin in mice. Gene 195 (1997) 19-27
16. De Bacquer D., De Backer G., Langlois M., Delanghe J., Kesteloot H., and Kornitzer M. Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis 157 (2001) 161-166
17. De Kleijn D.P., Smeets M.B., Kemmeren P.P., et al. Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring. FASEB J (2002) 16
18. Kurosky A., Barnett D.R., Lee T.H., et al. Covalent structure of human haptoglobin: a serine protease homolog. Proc Natl Acad Sci USA 77 (1980) 3388-3392
19. Uhlar C.M., and Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265 (1999) 501-523
20. Urieli-Shoval S., Linke R.P., and Matzner Y. Expression and function of serum amyloid A (SAA) a major acute phase protein, in normal and disease states. Curr Opin Hematol 7 (2000) 64-69
21. Urieli-Shoval S., Shubinsky G., Linke R.P., Fridkin M., Tabi I., and Matzner Y. Adhesion of human platelets to serum amyloid A. Blood 99 (2002) 1224-1229
22. Meek R.L., Urieli-Shoval S., and Benditt E.P. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci USA 91 (1994) 3186-3190